Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients

John Chalmers, Alain Castaigne, Trefor Morgan, Claude Chastang

Research output: Contribution to journalArticlepeer-review

70 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients'. Together they form a unique fingerprint.

Medicine & Life Sciences